Simulation in Transurethral Bladder Cancer Surgery
NCT03864302 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2021-08-24
Summary
Bladder cancer (BC) is the seventh most common cancer disease among men worldwide, and the fourth most common cancer in Danish men with an incidence of more than 2000 and a prevalence of 650 per 100000 citizens.
BC have a poor prognosis even when treated radically with cystectomy. The 5-year survival rate after radical cystectomy for T2 muscle-invasive tumors are 23-60 % and decreasing further to 23 % for T4 muscle-invasive tumors. BC is highly recurrent with an overall recurrence of 50 %.
BC is considered to be the number one cost-expensive malignant disease of all malignant diseases measured by lifetime per patient in the United States.
The degree of muscle invasion in the bladder is histologically and clinically defined by a transurethral resection of the bladder tumor (TUR-B). The tumor is resected radically if possible.
Thus, it is of absolute importance that a sufficient TURB is performed, since a resection to the muscle layer of the bladder wall, the detrusor, is of prognostic value for the patient.
Problem: The quality of the surgery is depending on the surgeon A recent international meta-analysis shows that up to 78% of the tumors are not radically resected. When these tumors are resected in a second TURB 24-28% of the tumors are found to be muscle-invasive.
Furter, there is evidence indicating that the outcome of the resection is dependent on surgeon experience.
Large multi-centre retrospective studies have showed that resident-involvement in TURB results in less radical bladder tumor resections and result in higher recurrence rates of bladder tumors and high numbers of re-admission after TURB.
In Denmark, the current surgical curriculum states that TURB is a learning goal in the first year of the training. The formal training in TURB in Denmark is traditional apprenticeship in accordance with the Halstedian principle "see one, do one, teach one". No validated simulator-based certification in TURB exits today in Denmark or internationally.
Purpose: Start from the beginning - improve the training of the surgeons Simulator-based training in surgical procedures is an effective method to gain surgical skills in a large spectrum of surgical procedures. In the initial phase of the learning curve it has even proven more effective than traditional apprenticeship and thus both the World Health Organization (WHO) and the European Association of Urology (EAU) calls for implementation of simulation training programmes in medical surgical education.
The aim of this project is to validate and develop a simulator-based urological training programme in TURB, to implement the programme nationally and internationally, and hereby improve the outcomes in the surgical treatment of patients with bladder cancer.
Conditions
- Virtual Reality
- Education
- Bladder Cancer
Interventions
- BEHAVIORAL
-
Motor Imagery
Motor imagery (MI) is a psychological technique for improvement of motor skills.(24) MI skill training (MIST) has been used and explored in several disciplines including Sports, Music, Education, Psychology and Medicine.(18) The literature has found positive effects on performances in professional athletes but also on rehabilitation of stroke patients.(25,26) MI is a cognitive imagery of a physical performance, e.g. a high jumper imagine a high jump, prior to performance. MI is not as effective as physical practice, but more effective compared to no training.(27) Further, MI combined with physical practice has been found to be more effective in skill performance in sports compared to physical practice alone.(18) MIST has shown promising results on surgical performances in flexible cystoscopy performed by doctors.(28)
Sponsors & Collaborators
-
Copenhagen Academy for Medical Education and Simulation
collaborator OTHER -
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Sarah Bube, MD · Zeland Region
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-06-01
- Primary Completion
- 2021-03-30
- Completion
- 2022-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy
NCT04943094 ·Status: ACTIVE_NOT_RECRUITING
-
MOdified Urinary Conduit to Lower Strictures After radIcal Cystectomy
NCT04391790 ·Status: UNKNOWN ·Phase: NA
-
Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer
NCT07180121 ·Status: ENROLLING_BY_INVITATION
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
Vascularized Composite Bladder Allograft Transplantation
NCT05462561 ·Status: RECRUITING ·Phase: NA
-
The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study
NCT03597087 ·Status: UNKNOWN ·Phase: NA
-
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
NCT05223491 ·Status: COMPLETED ·Phase: NA
-
3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
NCT01124682 ·Status: UNKNOWN ·Phase: PHASE1
-
Adaptive Radiotherapy Using Plan Selection for Bladder Cancer
NCT01762527 ·Status: COMPLETED ·Phase: NA
-
RESECT: Improving Quality in TURBT Surgery.
NCT05154084 ·Status: COMPLETED
-
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
NCT04617743 ·Status: UNKNOWN
-
Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
NCT06781879 ·Status: RECRUITING ·Phase: PHASE4
-
Image-Guided Tumorboost of Bladder Cancer
NCT00963404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11)
NCT07043543 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
NCT06427824 ·Status: RECRUITING ·Phase: NA
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer
NCT01840137 ·Status: COMPLETED ·Phase: NA
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Study of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02
NCT06780358 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Trimodality Treatment in Bladder Cancer
NCT06395701 ·Status: COMPLETED
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
Intravesical Adjuvant Electromotive Mitomycin-C
NCT01920269 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy
NCT04610385 ·Status: UNKNOWN
-
The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
NCT07077447 ·Status: RECRUITING